EUVIMEDEUVIMED entdecken
Scoping ReviewOpen Access · CC BY 4.0

A scoping review evaluating physical and cognitive functional outcomes in cancer survivors treated with chemotherapy: charting progress since the 2018 NCI think tank on cancer and aging phenotypes

Eine Scoping-Review zu körperlichen und kognitiven Funktionsoutcomes bei Krebssurvivor:innen nach Chemotherapie: Fortschritte seit dem NCI-Think-Tank 2018 zu Krebs und Altersphänotypen

Mostafa Mohamed, Mustafa Ahmed, AnnaLynn M Williams, Nikesha Gilmore, Po-Ju Lin, Sule Yilmaz, Marielle Jensen-Battaglia, Karen Mustian, Michelle Janelsins, Supriya Mohile

Journal of Cancer Survivorship · 2024-08 · 18 (4) · 1089-1130

DOI: 10.1007/s11764-024-01589-0 ↗

Auf einen Blick

Die Scoping-Review fasst Studien seit 2018 zu körperlicher und kognitiver Funktion sowie Frailty bei nach Chemotherapie behandelten Krebssurvivor:innen zusammen. Die meisten berichteten eine Verschlechterung.

Fragestellung

Wie entwickeln sich körperliche und kognitive Funktionsoutcomes sowie Frailty bei Krebssurvivor:innen nach Chemotherapie?

Methode

Scoping-Review; Suche in PubMed, Scopus und Web of Science nach Manuskripten von August 2018 bis Juli 2023; eingeschlossen waren beobachtende Studien.

Ergebnisse

989 potenziell relevante Artikel, 65 erfüllten die Kriterien. 49 longitudinal, 16 querschnittlich; 30 zu Brustkrebs, 20 zu 60 + Jahren, 17 zu Kindheitskrebsüberlebenden. Von 23 Studien zu körperlicher Funktion zeigten 82 % reduzierte Funktion; von 39 zu Kognition 74 % reduzierte Funktion; von 15 zu Frailty 80 % zunehmende Frailty.

Einschränkungen

22 % der Studien untersuchten biologische Mechanismen; prospektive Beobachtungsstudien mit mehreren Zeitpunkten werden benötigt, um die Befunde zu bestätigen.

Schlussfolgerung der Autor:innen

Chemotherapie ist bei Krebssurvivor:innen mit reduzierter körperlicher Funktion, reduzierter kognitiver Funktion und zunehmender Frailty assoziiert; diese Zusammenhänge zeigten sich in longitudinalen und querschnittlichen Studien.

Kernaussagen

  • 82 % der Studien zu körperlicher Funktion berichteten eine Verschlechterung
  • 74 % der Studien zu kognitiver Funktion berichteten eine Verschlechterung
  • Inflammation und epigenetische Alterung waren mit schlechteren Outcomes assoziiert

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Scoping Review in der Zeitschrift Journal of Cancer Survivorship, online erschienen am 14.05.2024. Verfasst von Mostafa Mohamed und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Rochester, Rochester, NY, USA. Hauptthemen laut MEDLINE: Cancer Survivors, Neoplasms, Cognition. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, the National Institute on Aging at the National Institute of Health, NIH HHS.

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

The primary goal of this scoping review was to summarize the literature published after the 2018 National Cancer Institute think tank, “Measuring Aging and Identifying Aging Phenotypes in Cancer Survivors,” on physical and cognitive functional outcomes among cancer survivors treated with chemotherapy. We focused on the influence of chemotherapy on aging-related outcomes (i.e., physical functional outcomes, cognitive functional outcomes, and frailty), given the known associations between chemotherapy and biologic mechanisms that affect aging-related physiologic processes.

Methods

A search was conducted across electronic databases, including PubMed, Scopus, and Web of Science, for manuscripts published between August 2018 and July 2023. Eligible studies: 1) included physical function, cognitive function, and/or frailty as outcomes; 2) included cancer survivors (as either the whole sample or a subgroup); 3) reported on physical or cognitive functional outcomes and/or frailty related to chemotherapy treatment (as either the whole sample or a subgroup); and 4) were observational in study design.

Results

The search yielded 989 potentially relevant articles, of which 65 met the eligibility criteria. Of the 65 studies, 49 were longitudinal, and 16 were cross-sectional; 30 studies (46%) focused on breast cancer, 20 studies (31%) focused on the age group 60 + years, and 17 (26%) focused on childhood cancer survivors. With regards to outcomes, 82% of 23 studies reporting on physical function showed reduced physical function, 74% of 39 studies reporting on cognitive functional outcomes found reduced cognitive function, and 80% of 15 studies reporting on frailty found increasing frailty among cancer survivors treated with chemotherapy over time and/or compared to individuals not treated with chemotherapy. Fourteen studies (22%) evaluated biologic mechanisms and their relationship to aging-related outcomes. Inflammation was consistently associated with worsening physical and cognitive functional outcomes and epigenetic age increases. Further, DNA damage was consistently associated with worse aging-related outcomes.

Conclusion

Chemotherapy is associated with reduced physical function, reduced cognitive function, and an increase in frailty in cancer survivors; these associations were demonstrated in longitudinal and cross-sectional studies. Inflammation and epigenetic age acceleration are associated with worse physical and cognitive function; prospective observational studies with multiple time points are needed to confirm these findings. Implications for cancer survivors This scoping review highlights the need for interventions to prevent declines in physical and cognitive function in cancer survivors who have received chemotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cancer SurvivorsNeoplasmsCognitionHumansAgingFrailtyPhenotypeAntineoplastic AgentsNational Cancer Institute (U.S.)

Stichwörter der Autor:innen

Accelerated agingAging phenotypesCancer survivorsChemotherapyCognitive functionPhysical function

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Department of Medicine, University of Rochester, Rochester, NY, USA.
  • Department of Surgery, University of Rochester, Rochester, NY, USA.
  • Department of Public Health, University of Rochester, Rochester, NY, USA.
  • Department of Medicine, University of Rochester, Rochester, NY, USA. supriya_mohile@urmc.rochester.edu.
  • Wilmot Cancer Institute, 601 Elmwood Avenue, Box 702, Rochester, NY, 14642, USA. supriya_mohile@urmc.rochester.edu.

Förderung

  • NCI NIH HHS
  • the National Institute on Aging at the National Institute of Health
  • NIH HHS
  • NIA NIH HHS
  • National Institutes of Health
  • National Institute on Aging at the National Institute of Health
  • National Cancer Institute

Zitieren

APA

Mohamed, M., Ahmed, M., Williams, A. M., Gilmore, N., Lin, P. J., Yilmaz, S., Jensen-Battaglia, M., Mustian, K., Janelsins, M., & Mohile, S. (2024). A scoping review evaluating physical and cognitive functional outcomes in cancer survivors treated with chemotherapy: charting progress since the 2018 NCI think tank on cancer and aging phenotypes. Journal of Cancer Survivorship, 18(4), 1089-1130. https://doi.org/10.1007/s11764-024-01589-0

Vancouver

Mohamed M, Ahmed M, Williams AM, Gilmore N, Lin PJ, Yilmaz S, et al. A scoping review evaluating physical and cognitive functional outcomes in cancer survivors treated with chemotherapy: charting progress since the 2018 NCI think tank on cancer and aging phenotypes. Journal of Cancer Survivorship. 2024;18(4):1089-1130. doi:10.1007/s11764-024-01589-0

BibTeX
@article{Mohamed2024,
  author = {Mohamed, Mostafa and Ahmed, Mustafa and Williams, AnnaLynn M and Gilmore, Nikesha and Lin, Po-Ju and Yilmaz, Sule and Jensen-Battaglia, Marielle and Mustian, Karen and Janelsins, Michelle and Mohile, Supriya},
  title = {A scoping review evaluating physical and cognitive functional outcomes in cancer survivors treated with chemotherapy: charting progress since the 2018 NCI think tank on cancer and aging phenotypes},
  journal = {Journal of Cancer Survivorship},
  year = {2024},
  volume = {18},
  number = {4},
  pages = {1089--1130},
  doi = {10.1007/s11764-024-01589-0}
}
Kostenlos starten →